Johnson & Johnson's ($JNJ) Janssen arm is planning to open another biotech incubator, this time setting its sights on South San Francisco in hopes of finding a few promising drug developers.
The new operation, dubbed Janssen Labs @South San Francisco, will be a 30,000-square-foot mix of lab and office space with room for up to 50 startups, J&J said. Mirroring Janssen's flagship San Diego incubator, the new facility will be staffed by some of J&J's biotech brains and provide operational support, education and business services to its guest companies.